Self-Designed Ningxin Anshen Formula for Treatment of Post-ischemic Stroke Insomnia: A Randomized Controlled Trial

This study aimed to assess the efficacy and safety of self-designed Ningxin Anshen (NXAS) Formula for post-ischemic stroke insomnia of blood-deficient and liver-heat syndrome. Ninety patients were randomized into NXAS group, Placebo group and Zopiclone group. Patients in the NXAS group, Placebo grou...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Ning, Li, Yuanyuan, Sun, Jing, Li, Feng, Xiong, Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680871/
https://www.ncbi.nlm.nih.gov/pubmed/33240190
http://dx.doi.org/10.3389/fneur.2020.537402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7680871/
https://www.ncbi.nlm.nih.gov/pubmed/33240190
http://dx.doi.org/10.3389/fneur.2020.537402

Ejemplares similares